Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)

被引：29
|
作者：
Boatman, P. Douglas [1 ]
Schrader, Thomas O. [1 ]
Kasem, Michelle [1 ]
Johnson, Benjamin R. [1 ]
Skinner, Philip J. [1 ]
Jung, Jae-Kyu [1 ]
Xu, Jerry [1 ]
Cherrier, Martin C. [1 ]
Webb, Peter J. [1 ]
Semple, Graeme [1 ]
Sage, Carleton R. [1 ]
Knudsen, Jens [1 ]
Chen, Ruoping [2 ]
Taggart, Andrew K. [3 ]
Carballo-Jane, Ester [3 ]
Richman, Jeremy G. [2 ]
机构：
[1] Arena Pharmaceut, Dept Med Chem, San Diego, CA 92121 USA
[2] Arena Pharmaceut, Dept Discovery Biol, San Diego, CA 92121 USA
[3] Merck Res Labs, Rahway, NJ USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 09期
关键词：
Niacin receptor; Free fatty acids; Vasodilation; Atherosclerosis; TERMINAL EPOXIDES; PROSTAGLANDIN D-2; LANGERHANS CELLS; NIACIN; MK-0354; DISEASE; HUMANS; DRUG; MICE;
D O I：
10.1016/j.bmcl.2010.03.062
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2797 / 2800
页数：4
相关论文
共 49 条
  • [41] Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
    Alexopoulou, Flora
    Bech, Esben Matzen
    Pedersen, Soren Ljungberg
    Thorbek, Ditte Dencker
    Leurs, Ulrike
    Rudkjaer, Lise Christine Biehl
    Fosgerau, Keld
    Hansen, Henrik H.
    Vrang, Niels
    Jelsing, Jacob
    Elster, Lisbeth
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP1, EP2, and EP4 in the niacin-induced flushing pathway
    Chiu, Chi-Wei
    Chen, Bao-Yu
    Lin, Jin-Jia
    Tseng, Huai-Hsuan
    Huang, Chih-Chun
    Wang, Tzu-Yun
    Jang, Fong-Lin
    Yao, Chi-Yu
    Chang, Wei-Hung
    Chen, Po-See
    Lin, Sheng-Hsiang
    SCHIZOPHRENIA RESEARCH, 2025, 280 : 30 - 38
  • [43] Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases
    Sun, Nannan
    Ma, Xiaojun
    Zhou, Kaifeng
    Zhu, Chen
    Cao, Zhonglian
    Wang, Yonghui
    Xu, Jun
    Fu, Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [44] GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
    Oh, Da Young
    Talukdar, Saswata
    Bae, Eun Ju
    Imamura, Takeshi
    Morinaga, Hidetaka
    Fan, WuQiang
    Li, Pingping
    Lu, Wendell J.
    Watkins, Steven M.
    Olefsky, Jerrold M.
    CELL, 2010, 142 (05) : 687 - 698
  • [45] Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters
    Singh, SB
    Ondeyka, JG
    Liu, WG
    Chen, S
    Chen, TS
    Li, XH
    Bouffard, A
    Dropinski, J
    Jones, AB
    McCormick, S
    Hayes, N
    Wang, JH
    Sharma, N
    MacNaul, K
    Hernandez, M
    Chao, YS
    Baffic, J
    Lam, MH
    Burton, C
    Sparrow, CP
    Menke, JG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (11) : 2824 - 2828
  • [46] Identification of a Potent and Selective Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist with Favorable Physicochemical and in Vitro ADME Properties
    Christiansen, Elisabeth
    Urban, Christian
    Grundmann, Manuel
    Due-Hansen, Maria E.
    Hagesaether, Ellen
    Schmidt, Johannes
    Pardo, Leonardo
    Ullrich, Susanne
    Kostenis, Evi
    Kassack, Matthias
    Ulven, Trond
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (19) : 6691 - 6703
  • [47] Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes
    Mikami, Satoshi
    Kitamura, Shuji
    Negoro, Nobuyuki
    Sasaki, Shinobu
    Suzuki, Masami
    Tsujihata, Yoshiyuki
    Miyazaki, Takeshi
    Ito, Ryo
    Suzuki, Nobuhiro
    Miyazaki, Junichi
    Santou, Takashi
    Kanzaki, Naoyuki
    Funami, Miyuki
    Tanaka, Toshimasa
    Yasuma, Tsuneo
    Momose, Yu
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3756 - 3776
  • [48] Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: Investigation of nicotinic acid receptor agonists
    Zgoda-Pols, Joanna R.
    Chowdhury, Swapan
    Wirth, Mark
    Milburn, Michael V.
    Alexander, Danny C.
    Alton, Kevin B.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 255 (01) : 48 - 56
  • [49] Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists
    Burkholder, Timothy P.
    Cunningham, Brian E.
    Clayton, Joshua R.
    Lander, Peter A.
    Brown, Matthew L.
    Doti, Robert A.
    Durst, Gregory L.
    Montrose-Rafizadeh, Chahrzad
    King, Constance
    Osborne, Harold E.
    Amos, Robert M.
    Zink, Richard W.
    Stramm, Lawrence E.
    Burris, Thomas P.
    Cardona, Guemalli
    Konkol, Debra L.
    Reidy, Charles
    Christe, Michael E.
    Genin, Michael J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) : 1377 - 1380
12345